Royal Philips has introduced the EPIQ CVx cardiovascular ultrasound system. Built on the powerful EPIQ ultrasound platform, EPIQ CVx is specifically designed to increase diagnostic confidence and simplify workflow for clinicians, giving them more time to interact with their patients and reducing the need for repeat scans.
The initial response to the new system has been overwhelmingly positive: 95% of a group of clinicians who were shown the new EPIQ CVx believed it offered improved image quality: sharper and clearer images.1 Philips is also introducing the EPIQ CVxi, specifically tailored for use in the interventional lab. EPIQ CVx and EPIQ CVxi are CE marked and have received 510(k) clearance from the US Food and Drug Administration (FDA).
“The EPIQ CVx brings together advanced image quality, quantification and intelligence specifically for the cardiologist,” said Roberto Lang, professor of Medicine, Director, Noninvasive Cardiac Imaging Laboratory at the University of Chicago Medicine. “I was impressed with the TrueVue feature, which elevates 3D ultrasound imaging to a totally new level and could impact diagnostic ability of echocardiography in different clinical scenarios, like better understanding of the anatomy of mitral valves.”
The EPIQ CVx includes TrueVue, giving clinicians the ability to see photorealistic renderings of the heart, which improves cardiac anatomy analysis by offering detailed tissue and depth perception imaging through a new virtual light source. The system provides cardiologists with high image quality through the latest generation OLED monitor, offering a more dynamic, wider viewing angle for side-by-side image comparison. By combining the new OLED monitor with TrueVue, clinicians can have the confidence to provide exceptional care for all patients, including pediatric patients, whose small hearts can be challenging to image.
The system offers a variety of new features including Dynamic Heart Model. Building on Philips HeartModelA.I., it uses anatomical intelligence to automatically quantify left ventricle function to produce a multi-beat analysis for adult patients. Dynamic Heart Model has been shown to reduce the amount of time to generate a 3D Ejection Fraction, an important measurement in determining how well the heart is pumping out blood, by 83%.2 It also delivers a high level of robustness and reproducibility, even for patients with an arrhythmia. The systems also includes the new S9-2 PureWave Transducer, which simplifies paediatric cardiac exams by displaying high levels of detail and contrast resolution through the single-crystal technology. It also provides tissue information at greater depths and enhances paediatric capability for coronary artery visualisation.
1. Results obtained during user demonstrations performed in December 2017 with the EPIQ CVx and the iE33 systems. The research was designed and supervised by Use-Lab GmbH, an independent and objective engineering consultancy and user interface design company. The tests involved 42 clinicians from 17 countries. The various types of cardiac customer segments represented were adult diagnostics and interventional, adult diagnostics, and pediatric diagnostics and interventional.
2. Prado A, Narang A, Volpato V, Kumari N, Prater D, Addetia K, Patel AR, Mor-Avi V, Lang RM: Automated dynamic measurement of left heart chamber volumes for quantification of ejection and filling parameters. JASE 31(6):B111; 2018